Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael

Showing results (1031-1040 of 1,257) with videos related to

Pageof 126
Sort By:
Journal of Cardiovascular Pharmacology|December 23, 2004
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury modelKai Wang, Khaldoun Tarakji, Zhongmin Zhou, et al.
American Heart Journal|August 9, 2005
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trialSorin J Brener, A Michael Lincoff, Eric R Bates, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 5, 2010
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trialGiuseppe Ambrosio, Steven Steinhubl, Paolo Gresele, et al.
Journal of Cardiovascular Electrophysiology|July 4, 2009
Transesophageal echocardiography for the prevention of embolic complications after catheter ablation for atrial fibrillationKevin A Michael, Damian P Redfearn, Adrian Baranchuk, et al.
Pediatric Nephrology (Berlin, Germany)|October 11, 2008
Human renal function maturation: a quantitative description using weight and postmenstrual ageMalin M Rhodin, Brian J Anderson, A Michael Peters, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trialJeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 10, 2010
Measurement of lymph node function from the extraction of immunoglobulin in lymphJ Charlotte Fowler, Tom Bennett Britton, Elena Provenzano, et al.
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trialAnirudh Kumar, Divyang R Patel, Kathy E Wolski, et al.
Biology Open|May 6, 2020
A novel and cost-effective <i>ex vivo</i> orthotopic model for the study of human breast cancer in mouse mammary gland organ cultureAkash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, et al.
Pageof 126

Showing results (1031-1040 of 1,257) with videos related to

Sort By:
Pageof 126
Journal of Cardiovascular Pharmacology|December 23, 2004
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury modelKai Wang, Khaldoun Tarakji, Zhongmin Zhou, et al.
American Heart Journal|August 9, 2005
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trialSorin J Brener, A Michael Lincoff, Eric R Bates, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 5, 2010
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trialGiuseppe Ambrosio, Steven Steinhubl, Paolo Gresele, et al.
Journal of Cardiovascular Electrophysiology|July 4, 2009
Transesophageal echocardiography for the prevention of embolic complications after catheter ablation for atrial fibrillationKevin A Michael, Damian P Redfearn, Adrian Baranchuk, et al.
Pediatric Nephrology (Berlin, Germany)|October 11, 2008
Human renal function maturation: a quantitative description using weight and postmenstrual ageMalin M Rhodin, Brian J Anderson, A Michael Peters, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trialJeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 10, 2010
Measurement of lymph node function from the extraction of immunoglobulin in lymphJ Charlotte Fowler, Tom Bennett Britton, Elena Provenzano, et al.
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trialAnirudh Kumar, Divyang R Patel, Kathy E Wolski, et al.
Biology Open|May 6, 2020
A novel and cost-effective <i>ex vivo</i> orthotopic model for the study of human breast cancer in mouse mammary gland organ cultureAkash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, et al.
Pageof 126